Advances in the histopathologic and ultrasonographic diagnosis and tre
atment of gestational trophoblastic diseases have been paralleled by p
rogress in understanding the molecular basis underlying the biologic a
lterations observed in gestational trophoblastic tumors and choriocarc
inoma cell lines.